Event
Axxam at SLAS Europe 2026 | Talk on Nanoliter Compound Management
Date: 19-21 May 2026
Location: Vienna, Austria
Alessio Perotti,
Automation Manager – Hit & Lead Discovery
Mariella Ferrari,
Team Leader – Compound Management
Meet Axxam at the conference
SLAS Europe brings together scientists and technology leaders working at the forefront of laboratory automation and drug discovery.
This year, Axxam will be there with Alessio Perotti, our Automation Manager, and Mariella Ferrari, Team Leader of the Compound Management team, contributing to discussions on how automation and miniaturization are reshaping compound management and screening workflows.
Join our talk at SLAS Europe
Mariella Ferrari will present:
“From an Acoustic Dispenser Solo to an Access Automation Orchestra: Axxam’s Journey into the Nanoliter-Scale Symphony of Compound Management”
📆 20 May
🕚 2:30 PM – 2:50 PM
📍 Exhibition Hall B – Exhibition Theatre (#124)
The session will be hosted by Beckman Coulter, Inc.
This presentation will explore how compound management strategies evolve when moving toward nanoliter-scale workflows.
About SLAS Europe 2026
Society for Laboratory Automation and Screening’s SLAS Europe 2026 Conference and Exhibition will take place from 19–21 May in Vienna, Austria, bringing together the European life sciences community working across laboratory automation, screening technologies, and drug discovery.
The conference program is organized around three core scientific tracks:
- Advances in Drug Discovery
- Advances in Laboratory Automation
- Screening Applications & Diagnostics
In addition to scientific presentations and educational sessions, SLAS Europe features technology showcases, networking opportunities, poster sessions, and discussions focused on emerging approaches shaping research and laboratory workflows.
Let’s connect in SLAS Europe
If you would like to discuss compound management strategies, screening workflows, or early drug discovery support, feel free to connect with our team during the conference.
About Axxam
Axxam is a Contract Research Organization (CRO) supporting early drug discovery through integrated assay development, screening, compound management, and advanced in vitro platforms.